{
    "id": "620588f9c9dfcb9c09000033",
    "question": "Can bergapten cause phototoxicity?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"To answer this question, we need to analyze the given documents and look for information about bergapten and its relationship to phototoxicity. Bergapten is a known photosensitizer, and its structure is similar to that of vitamin A. According to Document [0], photosensitivity disorders can be caused by drugs and chemicals that can absorb energy and transfer it to molecular oxygen, generating tissue-destructive chemical species, including ROS. Since bergapten is a photosensitizer, it can potentially cause phototoxicity. Additionally, Document [1] mentions that photosensitivity can be caused by drugs and chemicals that are absorbed by the skin and can transfer energy to molecular oxygen, leading to tissue-destructive chemical species. This suggests that bergapten could also cause phototoxicity. Furthermore, Document [2] lists bergapten as a photosensitizer that can cause phototoxic reactions. Based on this information, it is likely that bergapten can cause phototoxicity.\", \"answer_choice\": \"A\"}",
    "snippets": [
        {
            "id": "InternalMed_Harrison_4382",
            "title": "InternalMed_Harrison",
            "content": "Phototoxicity and Photoallergy These photosensitivity disorders are related to the topical or systemic administration of drugs and other chemicals. Both reactions require the absorption of energy by a drug or chemical with consequent production of an excited-state photosensitizer that can transfer its absorbed energy to a bystander molecule or to molecular oxygen, thereby generating tissue-destructive chemical species, including ROS. Phototoxicity is a nonimmunologic reaction that can be caused by drugs and chemicals, a few of which are listed in Table 75-3. The usual clinical manifestations include erythema resembling a sunburn reaction that quickly desquamates, or \u201cpeels,\u201d within several days. In addition, edema, vesicles, and bullae may occur."
        },
        {
            "id": "InternalMed_Harrison_4377",
            "title": "InternalMed_Harrison",
            "content": "The diagnosis of photosensitivity requires elicitation of a careful history in order to define the duration of signs and symptoms, the length of time between exposure to sunlight and the development of subjective symptoms, and visible changes in the skin. The age of onset can also be a helpful diagnostic clue; for example, the acute photosensitivity of erythropoietic protoporphyria almost always begins in childhood, whereas the chronic photosensitivity of porphyria cutanea tarda (PCT) typically begins in the fourth and fifth decades of life. A patient\u2019s history of exposure to topical and systemic drugs and chemicals may provide important diagnostic clues. Many classes of drugs can cause photosensitivity on the basis of either phototoxicity or photoallergy. Fragrances such as musk ambrette that were previously present in numerous cosmetic products are also potent photosensitizers."
        },
        {
            "id": "InternalMed_Harrison_4279",
            "title": "InternalMed_Harrison",
            "content": "Photosensitivity Eruptions Photosensitivity eruptions are usually most marked in sun-exposed areas but may extend to sun-protected areas. The mechanism is almost always phototoxicity. Phototoxic reactions resemble sunburn and can occur with first exposure to a drug. Blistering may occur in drug-related pseudoporphyria, most commonly with NSAIDs (Fig. 74-1). The severity of the reactions depends on the tissue level of the drug, its efficiency as a photosensitizer, and the extent of exposure to the activating wavelengths of ultraviolet (UV) light (Chap. 75). Common orally administered photosensitizing drugs include fluoroquinolones and tetracycline antibiotics. Other drugs less frequently encountered are chlorpromazine, thiazides, and NSAIDs. Voriconazole may result in severe photosensitivity, accelerated photo-induced aging, and cutaneous carcinogenesis in organ transplant recipients."
        },
        {
            "id": "InternalMed_Harrison_4383",
            "title": "InternalMed_Harrison",
            "content": "Photoallergy is much less common and is distinct in that it is an immunopathologic process. The excited-state photosensitizer may create highly unstable haptenic free radicals that bind covalently to macromolecules to form a functional antigen capable of evoking a delayed-type hypersensitivity response. Some drugs and chemicals that can produce photoallergy are listed in Table 75-4. The clinical manifestations typically differ from those of phototoxicity in that an intensely pruritic eczematous dermatitis tends to predominate and evolves into lichenified, thickened, \u201cleathery\u201d changes in sun-exposed areas. A small subset (perhaps 5\u201310%) of patients with photoallergy may develop a persistent exquisite hypersensitivity to light even when the offending drug or chemical is identified and eliminated, a condition known as persistent light reaction."
        },
        {
            "id": "InternalMed_Harrison_4386",
            "title": "InternalMed_Harrison",
            "content": "CHAPTER 75 Photosensitivity and Other Reactions to Light 390 by UV-B. Patients with chronic actinic dermatitis usually manifest a broad spectrum of UV hyperresponsiveness and require meticulous photoprotection, including avoidance of sun exposure, use of high-SPF (>30) sunscreens, and, in severe cases, systemic immunosuppression, such as with azathioprine. The management of drug photosensitivity involves first and foremost the elimination of exposure to the chemical agents responsible for the reaction and the minimization of sun exposure. The acute symptoms of phototoxicity may be ameliorated by cool moist compresses, topical glucocorticoids, and systemically administered NSAIDs. In severely affected individuals, a rapidly tapered course of systemic glucocorticoids may be useful. Judicious use of analgesics may be necessary. Photoallergic reactions require a similar management approach. Furthermore, patients with persistent light reaction and chronic actinic dermatitis must be"
        },
        {
            "id": "InternalMed_Harrison_4280",
            "title": "InternalMed_Harrison",
            "content": "Because UV-A and visible light, which trigger these reactions, are not easily absorbed by nonopaque sunscreens and are transmitted through window glass, photosensitivity reactions may be difficult to block. Photosensitivity reactions abate with removal of either the drug or UV radiation, use of sunscreens that block UV-A light, and treating the reaction as one would a sunburn. Rarely, individuals develop persistent reactivity to light, necessitating long-term avoidance of sun 379 exposure."
        },
        {
            "id": "InternalMed_Harrison_4379",
            "title": "InternalMed_Harrison",
            "content": "Many dermatologic conditions may be caused or aggravated by sunlight (Table 75-2). The role of light in evoking these responses may be dependent on genetic abnormalities ranging from well-described defects in DNA repair that occur in xeroderma pigmentosum to the inherited abnormalities in heme synthesis that characterize the porphyrias. The chromophore has been identified in certain photosensitivity diseases, but the energy-absorbing agent remains unknown in the majority."
        },
        {
            "id": "InternalMed_Harrison_4385",
            "title": "InternalMed_Harrison",
            "content": "Phototoxicity and photoallergy often can be diagnostically confirmed by phototest procedures. In patients with suspected photo-toxicity, determining the minimal erythemal dose (MED) while the patient is exposed to a suspected agent and then repeating the MED after discontinuation of the agent may provide a clue to the causative drug or chemical. Photopatch testing can be performed to confirm the diagnosis of photoallergy. In this simple variant of ordinary patch testing, a series of known photoallergens is applied to the skin in duplicate, and one set is irradiated with a suberythemal dose of UV-A. The development of eczematous changes at sites exposed to sensitizer and light is a positive result. The characteristic abnormality in patients with persistent light reaction is a diminished threshold to erythema evoked + Halogenated salicylanilides + Hypericin (St. John\u2019s wort) + + Musk ambrette + Piroxicam"
        },
        {
            "id": "InternalMed_Harrison_4333",
            "title": "InternalMed_Harrison",
            "content": "We acknowledge the contribution of Dr. Jean-Claude Roujeau to this chapter in the 17th edition. Photosensitivity and other 75 Reactions to Light Alexander G. Marneros, David R. Bickers Sunlight is the most visible and obvious source of comfort in the environment. The sun provides the beneficial effects of warmth and vitamin D synthesis. However, acute and chronic sun exposure also has pathologic consequences. Few effects of sun exposure beyond those affecting the skin have been identified, but cutaneous exposure to sunlight is the major cause of human skin cancer and can have immunosuppressive effects as well."
        },
        {
            "id": "Pharmacology_Katzung_6742",
            "title": "Pharmacology_Katzung",
            "content": "Topical medications useful in protecting against sunlight contain either chemical compounds that absorb ultraviolet light, called sunscreens, or opaque materials such as titanium dioxide that reflect light, called sunshades. The three classes of chemical compounds most commonly used in sunscreens are p-aminobenzoic acid (PABA) and its esters, the benzophenones, and the dibenzoylmethanes. Most sunscreen preparations are designed to absorb ultraviolet light in the ultraviolet B (UVB) wavelength range from 280 to 320 nm, which is the range responsible for most of the erythema and sunburn associated with sun exposure and tanning. Chronic exposure to light in this range induces aging of the skin and photocarcinogenesis. Para-aminobenzoic acid and its esters are the most effective available absorbers in the B region. Ultraviolet in the longer UVA range, 320\u2013400 nm, is also associated with skin aging and cancer."
        },
        {
            "id": "InternalMed_Harrison_4396",
            "title": "InternalMed_Harrison",
            "content": "Since photosensitivity of the skin results from exposure to sunlight, it follows that absolute avoidance of sunlight will eliminate these disorders. However, contemporary lifestyles make this approach impractical for most individuals. Thus better approaches to photoprotection have been sought. Natural photoprotection is provided by structural proteins in the epidermis, particularly keratins and melanin. The amount of melanin and its distribution in cells are genetically regulated, and individuals of darker complexion (skin types IV\u2013VI) are at decreased risk for the development of acute sunburn and cutaneous malignancy. Other forms of photoprotection include clothing and sunscreens. Clothing constructed of tightly woven sun-protective fabrics, irrespective of color, affords substantial protection. Wide-brimmed hats, long sleeves, and trousers all reduce direct exposure. Sunscreens are now considered over-the-counter drugs, and a monograph from the"
        },
        {
            "id": "Pharmacology_Katzung_6793",
            "title": "Pharmacology_Katzung",
            "content": "A topical 3% gel formulation of the nonsteroidal anti-inflammatory drug diclofenac (Solaraze) has shown moderate effectiveness in the treatment of actinic keratoses. The mechanism of action is unknown. As with other NSAIDs, anaphylactoid reactions may occur with diclofenac, and it should be given with caution to patients with known aspirin hypersensitivity (see Chapter 36). Aminolevulinic acid (ALA) is an endogenous precursor of photo-sensitizing porphyrin metabolites. When exogenous ALA is provided to the cell through topical applications, protoporphyrin IX (PpIX) accumulates in the cell. When exposed to light of appropriate wavelength and energy, the accumulated PpIX produces a photodynamic reaction resulting in the formation of cytotoxic superoxide and hydroxyl radicals. Photosensitization of actinic keratoses using ALA (Levulan Kerastick) and illumination with a blue light photodynamic therapy illuminator (BLU-U) is the basis for ALA photodynamic therapy."
        },
        {
            "id": "Pharmacology_Katzung_6743",
            "title": "Pharmacology_Katzung",
            "content": "The benzophenones include oxybenzone, dioxybenzone, and sulisobenzone. These compounds provide a broader spectrum of absorption from 250 to 360 nm, but their effectiveness in the UVB erythema range is less than that of PABA. The dibenzoylmethanes include Parsol and Eusolex. These compounds absorb wavelengths throughout the longer UVA range, with maximum absorption at 360 nm. Patients particularly sensitive to UVA wavelengths include individuals with polymorphous light eruption, cutaneous lupus erythematosus, and drug-induced photosensitivity. In these patients, dibenzoylmethane-containing sunscreen may provide improved photoprotection. Ecamsule (Mexoryl) appears to provide greater UVA protection than the dibenzoylmethanes and is less prone to photodegradation."
        },
        {
            "id": "InternalMed_Harrison_4402",
            "title": "InternalMed_Harrison",
            "content": "Not surprisingly, the major side effects of long-term UV-B photo-therapy and PUVA photochemotherapy mimic those seen in individuals with chronic sun exposure and include skin dryness, actinic keratoses, and an increased risk of skin cancer. Despite these risks, the therapeutic index of these modalities continues to be excellent. It is important to choose the most appropriate phototherapeutic approach for a specific dermatologic disease. For example, narrow-band UV-B has been reported in several studies to be as effective as PUVA photo-chemotherapy in the treatment of psoriasis but to pose a lower risk of skin cancer development than PUVA. CHAPTER 75 Photosensitivity and Other Reactions to Light"
        },
        {
            "id": "InternalMed_Harrison_4103",
            "title": "InternalMed_Harrison",
            "content": "Vesicles and bullae are also seen in contact dermatitis, both allergic and irritant forms (Chap. 71). When there is a linear arrangement of vesicular lesions, an exogenous cause or herpes zoster should be suspected. Bullous disease secondary to the ingestion of drugs can take one of several forms, including phototoxic eruptions, isolated bullae, Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN) (Chap. 74). Clinically, phototoxic eruptions resemble an exaggerated sunburn with diffuse erythema and bullae in sun-exposed areas. The most commonly associated drugs are doxycycline, quinolones, thiazides, NSAIDs, voriconazole, and psoralens. The development of a phototoxic eruption is dependent on the doses of both the drug and ultraviolet (UV)-A irradiation."
        },
        {
            "id": "InternalMed_Harrison_8281",
            "title": "InternalMed_Harrison",
            "content": "Toxic Agents and Drugs A number of chemicals with oxidative potential, whether medicinal or not, can cause hemolysis even in people who are not G6PD deficient (see above). Examples are hyperbaric oxygen (or 100% oxygen), nitrates, chlorates, methylene blue, dapsone, cisplatin, and numerous aromatic (cyclic) compounds. Other chemicals may be hemolytic through nonoxidative, largely unknown mechanisms; examples include arsine, stibine, copper, and lead. The HA caused by lead poisoning is characterized by basophilic stippling; it is in fact a phenocopy of that seen in P5N deficiency (see above), suggesting it is mediated at least in part by lead inhibiting this enzyme."
        },
        {
            "id": "InternalMed_Harrison_29156",
            "title": "InternalMed_Harrison",
            "content": "Avoiding sunlight exposure and wearing clothing designed to provide protection for conditions with chronic photosensitivity are essential. Oral \u03b2-carotene (120\u2013180 mg/dL) may improve tolerance to sunlight in some patients. The beneficial effects of \u03b2-carotene may involve quenching of singlet oxygen or free radicals. The dosage may need to be adjusted to maintain serum carotene levels in the recommended range of 10\u201315 mmol/L (600\u2013800 mg/dL). Mild skin discoloration due to carotenemia is the only significant side effect. Afamelanotide, an \u03b1-melanocyte-stimulating hormone (MSH) analogue has completed phase III clinical trials in the United States for patients with EPP and XLP."
        },
        {
            "id": "InternalMed_Harrison_4343",
            "title": "InternalMed_Harrison",
            "content": "Cutaneous Optics and Chromophores Chromophores are endogenous or exogenous chemical components that can absorb physical energy. Endogenous chromophores are of two types: (1) normal components of skin, including nucleic acids, proteins, lipids, and 7-dehydrocholesterol (the precursor of vitamin D); and (2) components that are synthesized elsewhere in the body and that circulate in the bloodstream and diffuse into the skin, such as porphyrins. Normally, only trace amounts of porphyrins are present in the skin, but, in selected diseases known as the porphyrias (Chap. 430), porphyrins are released into the circulation in increased amounts from the bone marrow and the liver and are transported to the skin, where they absorb incident energy both in the Soret band (around 400 nm; short visible) and, to a lesser extent, in the red portion of the visible spectrum (580\u2013660 nm). This energy absorption results in the generation of ROS that can mediate structural damage to the skin, manifested as"
        },
        {
            "id": "Pharmacology_Katzung_6741",
            "title": "Pharmacology_Katzung",
            "content": "Trioxsalen and methoxsalen are psoralens used for the repigmentation of depigmented macules of vitiligo. With the development of high-intensity long-wave ultraviolet fluorescent lamps, photo-chemotherapy with oral methoxsalen for psoriasis and with oral trioxsalen for vitiligo has been under intensive investigation. Psoralens must be photoactivated by long-wavelength ultraviolet light in the range of 320\u2013400 nm (ultraviolet A [UVA]) to produce a beneficial effect. Psoralens intercalate with DNA, and with subsequent UVA irradiation, cyclobutane adducts are formed with pyrimidine bases. Both monofunctional and bifunctional adducts may be formed, the latter causing interstrand cross-links. These DNA photoproducts may inhibit DNA synthesis. The major long-term risks of psoralen photochemotherapy are cataracts and skin cancer."
        },
        {
            "id": "InternalMed_Harrison_4344",
            "title": "InternalMed_Harrison",
            "content": "and, to a lesser extent, in the red portion of the visible spectrum (580\u2013660 nm). This energy absorption results in the generation of ROS that can mediate structural damage to the skin, manifested as erythema, edema, urticaria, or blister formation. It is of interest that photoexcited porphyrins are currently used in the treatment of nonmelanoma skin cancers and their precursor lesions, actinic keratoses. Known as photodynamic therapy, this modality generates ROS in the skin, leading to cell death. Topical photosensitizers used in photodynamic therapy are the porphyrin precursors 5-aminolevulinic acid and methyl aminolevulinate, which are converted to porphyrins in the skin. It is believed that photodynamic therapy targets tumor cells for destruction more selectively than it targets adjacent nonneoplastic cells. The efficacy of such therapy requires appropriate timing of the application of methyl aminolevulinate or 5-aminolevulinic acid to the affected skin followed by exposure to"
        },
        {
            "id": "Pathology_Robbins_1391",
            "title": "Pathology_Robbins",
            "content": "it not for the DNA repair mechanisms discussed earlier, the incidence of chemically induced cancers in all likelihood would be much higher. As mentioned previously, the rare hereditary disorders of DNA repair, including xeroderma pigmentosum, are associated with greatly increased risk for developing cancers induced by UV light and certain chemicals."
        },
        {
            "id": "InternalMed_Harrison_4389",
            "title": "InternalMed_Harrison",
            "content": "Heme cannot be reutilized and must be synthesized continuously. The two body compartments with the largest capacity for its production are the bone marrow and the liver. Accordingly, the porphyrias originate in one or the other of these organs, with an end result of excessive endogenous production of potent photosensitizing porphyrins. The porphyrins circulate in the bloodstream and diffuse into the skin, where they absorb solar energy, become photoexcited, generate ROS, and evoke cutaneous photosensitivity. The mechanism of porphyrin photosensitization is known to be photodynamic, or oxygen-dependent, and is mediated by ROS such as singlet oxygen and superoxide anions."
        },
        {
            "id": "InternalMed_Harrison_29138",
            "title": "InternalMed_Harrison",
            "content": "Acute attacks are treated as in AIP, and hemin should be started early in most cases. Other than avoiding sun exposure, there are few effective measures for treating the skin lesions. \u03b2-Carotene, phlebotomy, and chloroquine are not helpful. In the erythropoietic porphyrias, excess porphyrins from bone marrow erythrocyte precursors are transported via the plasma to the skin and lead to cutaneous photosensitivity. XLSA results from the deficient activity of the erythroid form of ALA synthase (ALA synthase 2) and is associated with ineffective erythropoiesis, weakness, and pallor."
        },
        {
            "id": "InternalMed_Harrison_4339",
            "title": "InternalMed_Harrison",
            "content": "CHAPTER 75 Photosensitivity and Other Reactions to Light 386 below 300 nm, 20% of radiation below 360 nm, and 33% of short visible radiation reach the basal cell layer in untanned human skin. In contrast, UV-A readily penetrates to the dermis and is capable of altering structural and matrix proteins that contribute to photoaging of chronically sun-exposed skin, particularly in individuals of light complexion. Thus, longer wavelengths can penetrate more deeply into the skin."
        },
        {
            "id": "InternalMed_Harrison_4387",
            "title": "InternalMed_Harrison",
            "content": "use of analgesics may be necessary. Photoallergic reactions require a similar management approach. Furthermore, patients with persistent light reaction and chronic actinic dermatitis must be meticulously protected against light exposure. In selected patients to whom chronic systemic high-dose glucocorticoids pose unacceptable risks, it may be necessary to employ an immunosuppressive drug such as azathioprine, cyclophosphamide, cyclosporine, or mycophenolate mofetil."
        },
        {
            "id": "InternalMed_Harrison_4388",
            "title": "InternalMed_Harrison",
            "content": "Porphyria The porphyrias (Chap. 430) are a group of diseases that have in common inherited or acquired derangements in the synthesis of heme. Heme is an iron-chelated tetrapyrrole or porphyrin, and the nonmetal chelated porphyrins are potent photosensitizers that absorb light intensely in both the short (400\u2013410 nm) and the long (580\u2013650 nm) portions of the visible spectrum."
        },
        {
            "id": "InternalMed_Harrison_4337",
            "title": "InternalMed_Harrison",
            "content": "The wavelengths between 400 and 700 nm are visible to the human eye. The photon energy in the visible spectrum is not capable of damaging human skin in the absence of a photosensitizing chemical. Without the absorption of energy by a molecule, there can be no photosensitivity. Thus, the absorption spectrum of a molecule is defined as the range of wavelengths it absorbs, whereas the action spectrum for an effect of incident radiation is defined as the range of wavelengths that evoke the response. Photosensitivity occurs when a photon-absorbing chemical (chromophore) present in the skin absorbs incident energy, becomes excited, and transfers the absorbed energy to various structures or to molecular oxygen."
        },
        {
            "id": "Pharmacology_Katzung_6794",
            "title": "Pharmacology_Katzung",
            "content": "Treatment consists of applying ALA 20% topical solution to individual actinic keratoses followed by blue light photodynamic illumination 14\u201318 hours later. Transient stinging or burning at the treatment site occurs during the period of light exposure. Patients must avoid exposure to sunlight or bright indoor lights for at least 40 hours after ALA application. Redness, swelling, and crusting of the actinic keratoses will occur and gradually resolve over a 3to 4-week time course. Allergic contact dermatitis to methyl ester may occur."
        },
        {
            "id": "InternalMed_Harrison_4398",
            "title": "InternalMed_Harrison",
            "content": "In addition to light absorption, a critical determinant of the sustained photoprotective effect of sunscreens is their water resistance. The FDA monograph has defined strict testing criteria for sunscreens that claim to possess a high degree of water resistance. Some degree of photoprotection can be achieved by limiting the time of sun exposure during the day. Since a large part of an individual\u2019s total lifetime sun exposure may occur by age 18, it is important to educate parents and young children about the hazards of sunlight. Simply eliminating exposure at midday will substantially reduce lifetime UVR exposure."
        },
        {
            "id": "Pharmacology_Katzung_6792",
            "title": "Pharmacology_Katzung",
            "content": "Ingenol mebutate (Picato) is derived from the sap of the Euphorbia peplus plant and has recently been approved for the topical treatment of actinic keratoses. The mechanism by which ingenol mebutate induces keratinocyte cell death is unknown. For the treatment of actinic keratoses on the face and scalp, the 0.015% gel should be applied once daily for 3 consecutive days. For actinic keratoses on the trunk and extremities, the 0.05% gel should be applied to the affected area daily for 2 consecutive days. Local skin reactions are to be expected with crusting, swelling, vesiculation, and possible ulceration. Caution must be taken to prevent eye exposure. Patients must wash their hands well after applying the gel and avoid transfer of the drug to the periocular area during and after application."
        },
        {
            "id": "InternalMed_Harrison_4384",
            "title": "InternalMed_Harrison",
            "content": "A very uncommon type of persistent photosensitivity is known as chronic actinic dermatitis. The affected patients are typically elderly men with a long history of preexisting allergic contact dermatitis or photosensitivity. These individuals are usually exquisitely sensitive to UV-B, UV-A, and visible wavelengths."
        },
        {
            "id": "InternalMed_Harrison_4100",
            "title": "InternalMed_Harrison",
            "content": "Diffuse hyperpigmentation that is due to drugs or metals can result from one of several mechanisms\u2014induction of melanin pigment formation, complexing of the drug or its metabolites to melanin, and deposits of the drug in the dermis. Busulfan, cyclophosphamide, 5-fluorouracil, and inorganic arsenic induce pigment production. Complexes containing melanin or iron plus the drug or its metabolites are seen in patients receiving minocycline, and a diffuse, blue-gray, muddy appearance within sun-exposed areas may develop, in addition to pigmentation of the mucous membranes, teeth, nails, bones, and thyroid. Administration of amiodarone can result in both a phototoxic eruption (exaggerated sunburn) and/or a slate-gray to violaceous discoloration of sun-exposed skin. Biopsy specimens of the latter show yellow-brown granules in dermal macrophages, which represent intralysosomal accumulations of lipids, amiodarone, and its metabolites. Actual deposits of a particular drug or metal in the skin"
        }
    ],
    "scores": [
        0.0379108037563497,
        0.03706958839565991,
        0.03461549917469808,
        0.033497823971431216,
        0.027841456712042884,
        0.025901839737721012,
        0.025022704568159113,
        0.024579438798077155,
        0.023814183345688165,
        0.022024683430709256,
        0.021527379135572573,
        0.01878969654199012,
        0.01871774687308668,
        0.018606338980354728,
        0.018375566370196342,
        0.018219461697722567,
        0.017653890824622535,
        0.017460675848573793,
        0.016998166172943998,
        0.016736694677871148,
        0.01588557516737675,
        0.015864527629233512,
        0.01577788649706458,
        0.015604128718882818,
        0.015258417942981703,
        0.015079365079365081,
        0.015073212747631352,
        0.014995511906647658,
        0.014955357142857142,
        0.01471304159679775,
        0.014609094535301157,
        0.014562167392356072
    ]
}